Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine

Br J Pharmacol. 2003 Jan;138(1):261-71. doi: 10.1038/sj.bjp.0705028.

Abstract

1 We have compared the signalling mechanisms involved in the pertussis toxin-sensitive and -insensitive contraction of rat isolated mesenteric microvessels elicited by sphingosylphosphorylcholine (SPC) and noradrenaline (NA), respectively. 2 The phospholipase D inhibitor butan-1-ol (0.3%), the store-operated Ca(2+) channel inhibitor SK>F 96,365 (10 microM), the tyrosine kinase inhibitor genistein (10 microM), and the src inhibitor PP2 (10 microM) as well as the negative controls (0.3% butan-2-ol and 10 microM diadzein and PP3) had only little effect against either agonist. 3 Inhibitors of phosphatidylinositol-3-kinase (wortmannin and LY 294,002, 10 microM each) or of mitogen-activated protein kinase kinase (PD 98,059 and U 126, 10 microM each) did not consistently attenuate NA- and SPC-induced contraction as compared to their vehicles or negative controls (LY 303,511 or U 124). 4 The phospholipase C inhibitor U 73,122 (10 microM) markedly inhibited the SPC- and NA-induced contraction (70% and 88% inhibition of the response to the highest NA and SPC concentration, respectively), whereas its negative control U 73,343 (10 microM) caused only less than 30% inhibition. 5 The rho-kinase inhibitors Y 27,632 (10 microM) and fasudil (30 microM) caused a rightward-shift of the NA concentration-response curve by 0.7-0.8 log units and reduced the response to 10 microM SPC by 88% and 83%, respectively. 6 These data suggest that SPC and NA, while acting on different receptors coupling to different G-protein classes, elicit contraction of rat mesenteric microvessels by similar signalling pathways including phospholipase C and rho-kinase.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Female
  • Male
  • Microcirculation / drug effects
  • Microcirculation / physiology
  • Norepinephrine / pharmacology*
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / pharmacology*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology*
  • Splanchnic Circulation / drug effects*
  • Splanchnic Circulation / physiology
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology

Substances

  • sphingosine phosphorylcholine
  • Phosphorylcholine
  • Sphingosine
  • Norepinephrine